Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation
Pallab Kar, Vijay Kumar, Balachandar Vellingiri, Arnab Sen, Nishika Jaishee, Akash Anandraj, Himani Malhotra, Subires Bhattacharyya, Subhasish Mukhopadhyay, Masako Kinoshita, Vivekanandhan Govindasamy, Ayan Roy, Devashan Naidoo, Mohana Devi Subramaniam
Abstract
towards deployment as efficient SARS-CoV-2 inhibitors and development of novel effective therapeutics.Communicated by Ramaswamy H. Sarma.
Topics & Concepts
In silicoDruggabilityComputational biologyBiologyProteaseDocking (animal)Context (archaeology)CoronavirusRNA-dependent RNA polymerasePharmacologyVirologyEnzymeBiochemistryCoronavirus disease 2019 (COVID-19)MedicinePolymeraseDiseaseInfectious disease (medical specialty)GenePathologyNursingPaleontologyComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchPhytochemicals and Medicinal Plants